A pregnant patient with ALK‑positive non‑small cell lung cancer treated with alectinib: A case report and review of the literature-Reference-Cited by-同舟云学术

A pregnant patient with ALK‑positive non‑small cell lung cancer treated with alectinib: A case report and review of the literature

Published:2022-12-20 Issue:2 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

De Smedt Fabian¹,Dessy Frédérique²,Carestia Luciano³,Baldin Pamela⁴,Nana Frank⁵,Clapuyt Philippe⁶,Boon Véronique⁷,Amant Frédéric⁸,Gziri Mina²

Affiliation:

1. Department of Obstetrics, Clinique Saint‑Pierre, 1340 Ottignies, Belgium

2. Department of Obstetrics, Cliniques Universitaires Saint‑Luc, 1200 Brussels, Belgium

3. Department of Pneumology, Clinique Saint‑Pierre, Avenue Reine Fabiola 9, 1340 Ottignies, Belgium

4. Department of Pathology, Cliniques Universitaires Saint‑Luc, 1200 Brussels, Belgium

5. Department of Pneumology, Cliniques Universitaires Saint‑Luc, 1200 Brussels, Belgium

6. Department of Radiology, Cliniques Universitaires Saint‑Luc, 1200 Brussels, Belgium

7. Department of Obstetrics, Clinique Saint‑Pierre, 1340 Ottignies; 2Department of Obstetrics, Cliniques Universitaires Saint‑Luc, 1200 Brussels, Belgium

8. Department of Gynecologic Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Making the first move in EGFR-driven or ALK-driven NSCLC: First-generation or next-generation TKI?;Recondo;Nat Rev Clin Oncol,2018

3. Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-small cell lung cancer;Pacheco;J Thorac Oncol,2019

4. Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world;Shokoohi;Cancer Med,2022

5. Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer;Cameron;Cochrane Database Syst Rev,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregnancy;Journal of Thoracic Oncology;2024-06

2. Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes;American Society of Clinical Oncology Educational Book;2024-06

3. Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy;BMJ Case Reports;2024-03

4. Non-small cell lung cancer with bone metastasis and pneumocystis pneumonia in a pregnant woman: a case report and literature review;BMC Infectious Diseases;2023-11-14

5. ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report;Clinical Lung Cancer;2023-11